Y Mabs Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $34M | 2.1M | 16.26 |
| 2023-12-31 | $15M | 2.2M | 6.82 |
| 2023-09-30 | $12M | 2.2M | 5.45 |
| 2023-06-30 | $15M | 2.2M | 6.79 |
| 2023-03-31 | $11M | 2.3M | 5.01 |
| 2022-12-31 | $11M | 2.3M | 4.88 |
| 2022-06-30 | $29M | 1.9M | 15.13 |
| 2022-03-31 | $21M | 1.8M | 11.88 |
| 2021-09-30 | $52M | 1.8M | 28.54 |
| 2021-06-30 | $55M | 1.6M | 33.81 |
| 2021-03-31 | $48M | 1.6M | 30.24 |
| 2020-12-31 | $73M | 1.5M | 49.52 |
| 2020-09-30 | $48M | 1.2M | 38.39 |
| 2020-06-30 | $54M | 1.2M | 43.19 |
| 2020-03-31 | $28M | 1.1M | 26.10 |
| 2019-12-31 | $33M | 1.1M | 31.25 |
| 2019-09-30 | $19M | 743k | 26.05 |
| 2019-03-31 | $7.5M | 285k | 26.23 |
| 2018-12-31 | $5.2M | 257k | 20.31 |
| 2018-09-30 | $2.2M | 85k | 26.42 |